Nutrien (NYSE:NTR) had its price objective upped by investment analysts at Macquarie from $59.00 to $66.00 in a research report issued on Friday, Stock Target Advisor reports. The firm presently has an “outperform” rating on the stock. Macquarie’s price target suggests a potential upside of 22.06% from the company’s current price.

A number of other analysts have also issued reports on the stock. Royal Bank of Canada set a $65.00 target price on shares of Nutrien and gave the stock a “buy” rating in a research report on Tuesday, October 2nd. UBS Group raised their target price on shares of Nutrien from $63.00 to $66.00 and gave the stock a “buy” rating in a research report on Tuesday, October 2nd. Scotiabank lowered shares of Nutrien from a “focus list” rating to an “outperform” rating in a research report on Thursday, September 20th. BMO Capital Markets restated a “hold” rating and set a $55.00 target price on shares of Nutrien in a research report on Wednesday, September 19th. Finally, Zacks Investment Research upgraded shares of Nutrien from a “hold” rating to a “buy” rating and set a $61.00 target price on the stock in a research report on Saturday, September 8th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $62.12.

Shares of NYSE NTR opened at $54.07 on Friday. Nutrien has a 1 year low of $40.41 and a 1 year high of $58.99.

Nutrien (NYSE:NTR) last announced its earnings results on Wednesday, August 1st. The company reported $1.48 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.40 by $0.08. Nutrien had a net margin of 9.83% and a return on equity of 10.27%. The firm had revenue of $8.15 billion for the quarter, compared to analyst estimates of $7.70 billion. The business’s revenue for the quarter was up 10.8% on a year-over-year basis. On average, sell-side analysts forecast that Nutrien will post 2.55 earnings per share for the current year.

Institutional investors and hedge funds have recently made changes to their positions in the business. Great West Life Assurance Co. Can boosted its holdings in shares of Nutrien by 1.9% in the 2nd quarter. Great West Life Assurance Co. Can now owns 5,110,815 shares of the company’s stock valued at $278,927,000 after purchasing an additional 95,380 shares during the last quarter. Bank of Nova Scotia boosted its holdings in shares of Nutrien by 4.9% in the 2nd quarter. Bank of Nova Scotia now owns 2,536,579 shares of the company’s stock valued at $137,340,000 after purchasing an additional 118,546 shares during the last quarter. Oppenheimer & Co. Inc. boosted its holdings in shares of Nutrien by 8.5% in the 2nd quarter. Oppenheimer & Co. Inc. now owns 39,340 shares of the company’s stock valued at $2,140,000 after purchasing an additional 3,088 shares during the last quarter. Morgan Stanley boosted its holdings in shares of Nutrien by 2.9% in the 2nd quarter. Morgan Stanley now owns 1,599,898 shares of the company’s stock valued at $87,002,000 after purchasing an additional 45,417 shares during the last quarter. Finally, US Bancorp DE boosted its holdings in shares of Nutrien by 17.1% in the 2nd quarter. US Bancorp DE now owns 43,311 shares of the company’s stock valued at $2,354,000 after purchasing an additional 6,327 shares during the last quarter. Institutional investors own 66.34% of the company’s stock.

Nutrien Company Profile

Nutrien Ltd. produces and markets crop nutrients worldwide. The company offers potash, nitrogen, phosphate, and solid and liquid phosphate fertilizers; and phosphate feed, ammonium sulfate, and industrial acid products. It also retails seeds, crop protection and crop nutrient products, merchandise products, and agronomic services through operating 1,500 retail locations.

Featured Story: What is an Initial Public Offering (IPO)?

Stock Target Advisor

Analyst Recommendations for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.